Phenotypic and activation surface markers of PBLs and RV cells on 3 representative donors
Surface marker . | Donor 1 . | Donor 2 . | Donor 3 . | |||
---|---|---|---|---|---|---|
PBLs % . | RV cells % . | PBLs % . | RV cells % . | PBLs % . | RV cells % . | |
CD2 | 90 | 97 | 79 | 99 | 77 | 100 |
CD3 | 84 | 97 | 64 | 82 | 76 | 97 |
CD4 | 65 | 45 | 45 | 22 | 55 | 36 |
CD8 | 25 | 58 | 23 | 55 | 29 | 56 |
CD56 | 8 | 12 | 27 | 19 | 20 | 9 |
CD19 | 8 | 0 | 12 | 0 | 4 | 5 |
CD25 | 1 | 2 | 3 | 1 | 4 | 7 |
HLA-DR | 25 | 85 | 37 | 87 | 24 | 92 |
CD69 | 12 | 21 | 30 | 65 | 16 | 54 |
CD95 | 10 | 72 | 14 | 94 | 40 | 99 |
CD45RA | 42 | 5 | 43 | 1 | 43 | 6 |
CD45RO | 40 | 91 | 56 | 99 | 57 | 97 |
CD62L | 74 | 56 | 46 | 27 | 67 | 51 |
CD28 | 67 | 51 | 68 | 33 | 68 | 33 |
Surface marker . | Donor 1 . | Donor 2 . | Donor 3 . | |||
---|---|---|---|---|---|---|
PBLs % . | RV cells % . | PBLs % . | RV cells % . | PBLs % . | RV cells % . | |
CD2 | 90 | 97 | 79 | 99 | 77 | 100 |
CD3 | 84 | 97 | 64 | 82 | 76 | 97 |
CD4 | 65 | 45 | 45 | 22 | 55 | 36 |
CD8 | 25 | 58 | 23 | 55 | 29 | 56 |
CD56 | 8 | 12 | 27 | 19 | 20 | 9 |
CD19 | 8 | 0 | 12 | 0 | 4 | 5 |
CD25 | 1 | 2 | 3 | 1 | 4 | 7 |
HLA-DR | 25 | 85 | 37 | 87 | 24 | 92 |
CD69 | 12 | 21 | 30 | 65 | 16 | 54 |
CD95 | 10 | 72 | 14 | 94 | 40 | 99 |
CD45RA | 42 | 5 | 43 | 1 | 43 | 6 |
CD45RO | 40 | 91 | 56 | 99 | 57 | 97 |
CD62L | 74 | 56 | 46 | 27 | 67 | 51 |
CD28 | 67 | 51 | 68 | 33 | 68 | 33 |